Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare System.

Author: AkeroydJulia M, Al RifaiMahmoud, BallantyneChristie M, GobbelGlenn, JiaXiaoming, KrittanawongChayakrit, LeeMichelle T, MahttaDhruv, MathenyMichael E, PetersenLaura A, RamseyDavid J, StoneNeil J, ViraniSalim S

Paper Details 
Original Abstract of the Article :
PURPOSE: Statin-associated side effects (SASEs) can limit statin adherence and present a potential barrier to optimal statin utilization. How standardized reporting of SASEs varies across medical facilities has not been well characterized. METHODS: We assessed facility-level variation in SASE repor...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s10557-021-07148-4

データ提供:米国国立医学図書館(NLM)

Statin-Associated Side Effects: A Call for Standardization in Reporting

The use of [statins] is a cornerstone of [atherosclerotic cardiovascular disease (ASCVD)] management, but it's not without its challenges. This study investigates the variation in [statin-associated side effects (SASEs)] reporting across different medical facilities.

The researchers analyzed data from the [Veterans Affairs (VA) healthcare system], finding significant facility-level variation in SASE reporting. This suggests that there is room for improvement in standardizing the documentation of SASEs, which could ultimately lead to better statin utilization and improved patient outcomes.

Standardizing SASE Reporting: A Key to Optimizing Statin Therapy

The study highlights the importance of standardized reporting of SASEs to ensure consistent and accurate data collection. This would allow for a better understanding of the true incidence of SASEs and inform more effective strategies for managing these side effects. This is like creating a well-maintained path through the desert of ASCVD treatment, ensuring that patients receive the appropriate care and guidance.

Navigating the Desert of ASCVD: A Need for Consistent Data Collection

This study underscores the need for consistent and reliable data collection in healthcare. By standardizing SASE reporting, we can better understand the impact of statins on patients and optimize their use to improve patient outcomes and quality of life. It's like finding a reliable map to navigate the complex landscape of ASCVD management, ensuring that patients receive the best possible care.

Dr.Camel's Conclusion

This study is a reminder that the journey through ASCVD treatment requires a clear map and consistent navigation. Standardizing SASE reporting can provide a more accurate and reliable roadmap for managing ASCVD, ensuring that patients receive the best possible care and achieve optimal health outcomes.

Date :
  1. Date Completed 2022-05-05
  2. Date Revised 2022-05-05
Further Info :

Pubmed ID

33523335

DOI: Digital Object Identifier

10.1007/s10557-021-07148-4

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.